Showing results (1151-1160 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|September 4, 2009
Shortcut formulae for pharmacokinetic dosage adjustmentsRobert J BellotoClinical Pharmacokinetics|September 4, 2009
Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjectsJuan José Pérez-Ruixo, Wojciech Krzyzanski, Esther Bouman-Thio, et al.Clinical Pharmacokinetics|September 4, 2009
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipientsPål Falck, Karsten Midtvedt, Thanh Trúc Vân Lê, et al.Clinical Pharmacokinetics|July 1, 1990
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part I)K Lauritsen, L S Laursen, J Rask-MadsenClinical Pharmacokinetics|September 12, 2009
Bioequivalence criteria for transdermal fentanyl generics: do these need a relook?Carmen Walter, Lisa Felden, Jörn LötschClinical Pharmacokinetics|September 12, 2009
Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantationFranck Saint-Marcoux, Bernard Royer, Jean Debord, et al.Clinical Pharmacokinetics|December 24, 2005
Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteersMona Darwish, Kenneth Tempero, Mary Kirby, et al.Clinical Pharmacokinetics|December 24, 2005
Penetration of orally administered prulifloxacin into human lung tissueErcole Concia, Benedetta Allegranzi, Giovanni B Ciottoli, et al.Clinical Pharmacokinetics|December 24, 2005
Population pharmacokinetics of olmesartan following oral administration of its prodrug, olmesartan medoxomil: in healthy volunteers and hypertensive patientsKazutaka Yoshihara, Yuying Gao, Hiroshi Shiga, et al.Clinical Pharmacokinetics|February 23, 2010
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part IChristine E Staatz, Lucy K Goodman, Susan E TettPageof 348